期刊文献+

大剂量甲基强的松龙冲击治疗Graves眼病40例 被引量:1

High-dose Methylprednisolone Therapy Forty Patients with Graves Oculopathy
在线阅读 下载PDF
导出
摘要 目的探讨大剂量甲基强的松龙冲击治疗Graves眼病(GO)的疗效。方法40例GO患者每日静脉滴注大剂量甲基强的松龙(1000mg/d)3—5d,继以醋酸泼尼松lmg/(kg·d)口服,逐渐减量至最小维持量,维持至3—6个月停药。结果总有效率92%,畏光流泪、结膜充血水肿有效率达100%,眼部异物感改善率96.9%,眼球活动减少改善率96.2%,复视改善率96.4%,视力减退改善率81.8%,斜视改善率83.3%,突眼改善率82.9%。结论大剂量甲基强的松龙冲击治疗有利于GO的改善。 Objective To investigate the effect of high - dose methylpredinisolone to Graves oculopathy. Methods Forty patients with Graves oculopathy were administered high- dose methyl- prednisolone( 1000 mg/d) by intravenous injections for three to five days,then they were given prednisone acetate with dose of lmg/(kg · d). Prednisone was reduced step by step to minimal maintenance dose,and was maintained for three to six months. Results Total effective rate was 92%. Effective rate was 100% on photophobia, lachrymation, hyperemia and edema of conjunctiva. Improvement rates were 96.9% on foreign body sensation,96.4% on diplopia, 81.8 % on hypopsia,83.3 % on anorthopia , and 82.9% on exophthalmos respectively. Conclusion High -dose methylpredinisolone is effective to improve Graves oculopathy.
作者 汪茂荣 姚平
出处 《湖北民族学院学报(医学版)》 2008年第1期45-46,共2页 Journal of Hubei Minzu University(Medical Edition)
关键词 GRAVES眼病 甲基强的松龙 大剂量 Graves oculopathy Methylprednisolone High - dose
作者简介 汪茂荣(1973-),女,湖北恩施人,硕士,主治医师。主要研究方向:内分泌代谢。
  • 相关文献

参考文献4

二级参考文献7

  • 1孙丰源 罗清礼.甲状腺相关眼病.眼眶病学[M].北京:人民卫生出版社,1999.342-369.
  • 2Rosthoj S, Nielsen S, Pedersen FK. Randomized comparison of Intravenous immunoglobulin and methylpreduisolone pulse therapy in children with newly diagnosed idiopathic thrombocytopenia purpura [ J ]. Danish ITP Study Group. Acta Paediatr, 1996,85:910 ~ 591.
  • 3Albayrak D, Islek I, Kalayci AG, et al. Acute immune thrombocytopenic purpura: Acomparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin[ J ]. J Pediatr, 1994,125:1004 ~ 1007.
  • 4Ozsoylu S, Irken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura [ J ]. Eur J Haematol, 1989,42:431 ~435.
  • 5Bussel JB, Corrigan JJ. Platelet and vascular disorders. In:Miller DR, Baehener RL, eds. Blood Diseases of Infancy and Childhood,7th ed. St [ J ]. Louis: Mosby, 1995: 878 ~886.
  • 6Scribner CL, Kapit RM, Phillips ET, et al. Aseptic meningitis and intravenous immunoglobuIin therapy [ J ]. Ann Intern Med 1994,121:305 ~ 305.
  • 7Jayabose S, Mahmoud M, Levendoglu -Tugal O, et al.Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura [ J ]. J Pediatr Hematol Oncol 1999,21:514 ~517.

共引文献24

同被引文献24

  • 1姜玉华,牛德红,侯华英,蒋铃,程玉峰.球后放射治疗Graves眼病30例疗效观察[J].山东医药,2006,46(29):59-60. 被引量:5
  • 2郑志刚.大剂量甲基泼尼松龙冲击治疗Graves眼病疗效观察[J].现代中西医结合杂志,2007,16(19):2686-2687. 被引量:5
  • 3侯华英,姜玉华,程玉峰,孙嗣伟.糖皮质激素联合球后放射治疗Graves眼病[J].山东医药,2007,47(30):79-80. 被引量:1
  • 4Wakelkamp IM,Baldeschi L,Saeed P,et al.Surgical or medical decompression as a first-line treatment of optic neurepathy in Graves'ophthalmopathy? A randomized controlled trtal[J].Clin Endocrinol(Oxf),2005,63(3):323-328.
  • 5Perros P,Kendall Taylor P.Medical treatment for thyroid associated ophthal mopathy[J].Thyroid,2002,12(3):241-244.
  • 6Bartalena L,Tanda ML.Clinical practice.Graves' oph-thalmopathy[J].N Engl J Med,2009,360(10):994-1001.
  • 7Kahaly GJ,Pitz S,Hommel G,et al.Randomized,single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy[J].J Clin Endocrinol Metab,2005,90(9):5234-5240.
  • 8Marino M,Morabito E,Brunetto MR,et al.Acute and $ cvcre liver damage associated with intravenous glucocortieoid pulse therapy in patients with Graves' ophthalmopathy[J].Thyroid,2004,14(5):403-406.
  • 9Le Moli R,Baldesehi L,Saeed P,et al.Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy[J].Thyroid,2007,17(4):357-362.
  • 10Ebner R,Devoto MH,W eil D,et al.Treatment of thyroid associated ophthalmopathy with periocular injections of triancinolonel[J].Br J Ophthalmol,2004,88(11):1380-1386.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部